The evidence suggests that the inflammation-sensitive nuclear factor kappa B (NF-κB) and signal transducer and activator of transcription 3 (STAT3) pathways may contribute to muscle atrophy in T2DM (Perry et al., 2016). This evidence concerns the gene STAT3 and type 2 diabetes mellitus.